In solid cancer, Morita et al [95] showed that inhibition of vascular E-Selectin enhanced the anti-tumor effect of Doxorubicin and reduced tumor infiltration of pro-tumoral macrophage M2. This evidence concerns the gene SELE and neoplasm.